Table 2.
|
Single biomarkers |
Biomarkers combinations |
|||||
---|---|---|---|---|---|---|---|
Biomarker | Frx | t-Tf | t-tau | Frx & t-Tf | Frx & t-tau | t-Tf & t-tau | Frx & t-Tf & t-tau |
Area under ROC (95% CI) | 0.75 (0.67–0.84) | 0.89 (0.84–0.95) | 0.82 (0.74–0.90) | 0.94 (0.89–0.98) | 0.83 (0.75–0.90) | 0.93 (0.88–0.97) | 0.95 (0.92–0.99) |
Sensitivity (95% CI) | 85.7 (76.4–91.9) | 87.9 (79–93.5) | 87.9 (79–93.5) | 86.8 (77.7–92.7) | 85.7 (76.4–91.9) | 85.7 (76.4–91.9) | 90.1 (81.6–95.1) |
Specificity (95% CI) | 49.1 (35.3–63) | 71.7 (57.4–82.8) | 69.8 (55.5–81.3) | 92.5 (80.9–97.6) | 66.0 (51.6–78.1) | 83.0 (69.7–91.5) | 90.6 (78.6–96.5) |
Positive LR (95% CI) | 1.7 (1.3–2.2) | 3.1 (2–4.8) | 2.9 (1.9–4.4) | 11.5 (4.5–29.6) | 2.5 (1.7–3.7) | 5 (2.8–9.2) | 9.6 (4.1–22.1) |
Negative LR (95% CI) | 0.3 (0.2–0.5) | 0.2 (0.1–0.3) | 0.2 (0.1–0.3) | 0.1 (0.1–0.2) | 0.2 (0.1–0.4) | 0.2 (0.1–0.3) | 0.1 (0.1–0.2) |
PPV (%) (95% CI) | 74.30 (64.7–82.1) | 84.2 (75–90.6) | 83.3 (74–89.9) | 95.2 (87.5–98.4) | 81.3 (71.7–88.2) | 89.7 (80.8–94.9) | 94.3 (86.5–97.9) |
NPV (%) (95% CI) | 66.70 (49.7–80.4) | 77.60 (63–87.8) | 77.1 (62.3–87.5) | 80.3 (67.8–89) | 72.90 (57.9–84.3) | 77.20 (63.8–86.8) | 84.2 (71.6–92.1) |
AIC | 1.16 | 0.79 | 1.18 | 0.62 | 1.07 | 0.68 | 0.57 |
Accuracy | 72.2 | 81.9 | 81.3 | 88.9 | 78.5 | 84.7 | 90.3 |
CJD (n=91) vs. DM (n=53).
Samples with all three biomarker values were used for this analysis.